Novel substituted bis-(3-cyano-2-pyridone) derivatives were prepared via a powerful method using enaminonitriles push-pull dienes as key building blocks. The synthesis was performed in three-steps from easily accessible starting materials in good yields. All target products were structurally elucidated by spectroscopic data. The reaction mechanism for formation of bis (3cyano-2-pyridone) derivatives was proposed. The structures of enaminonitriles 3a and bispyridones 4c were confirmed by single-crystal X-ray diffraction. The florescent study of some bis (3-cyano-2-pyridones) derivatives was reported.
The amine‐promoted rearrangement of 3‐halogenated and 3‐tosylated flavones into amino‐substituted aurones is a reliable but little‐explored method in aurone synthesis. We extend it to 8‐azaflavones, readily prepared from 3‐cyano‐2‐pyridones by the Baker‐Venkataraman methodology. They rearrange into 7‐azaaurones under mild conditions in the presence of a broad range of aliphatic primary and secondary amines, including bulky amines for which steric hindrance issues are overcome by Lewis base organocatalysis. Primary amines selectively give the E configuration through an intramolecular stabilising hydrogen bond between the amino substituent and the carbonyl oxygen. Suppressing such hydrogen bonds by N‐acylation allows accessing the Z configuration by simple photoisomerization. Thus, we propose a methodology that allows access to the 7‐azaaurone scaffold and allows controlling the E/Z configuration by switching from an amino to an amido substituent at the double bond. Finally, the rearrangement‐acylation‐photoisomerization sequence is successfully extended to 2‐ethylidenefuropyridin‐3‐ones.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.